All posts by admin

TechAccel and Iowa Corn Opportunities Invest in Agrivida

KANSAS CITY, Mo.—February 9, 2017—TechAccel and Iowa Corn Opportunities today announced separate investments in Agrivida Inc., a St. Louis-based agriculture technology company focused on animal nutrition.

These strategic investments come on the heels of Agrivida’s announcement of a $20.4M Series E financing round completed in September 2016. Terms of TechAccel and Iowa Corn Opportunities investments were not disclosed.

“We see Agrivida and its technology as a great new platform for using corn as a cost-competitive factory for a wide variety of products,” said Brian Jones, Chief Operating Officer of the Iowa Corn Growers Association, parent company of Iowa Corn Opportunities.

“Agrivida is poised to create a disruption across enzyme manufacturing and animal nutrition,” said Michael Helmstetter, Ph.D., President and CEO of TechAccel, a venture and technology development firm. “Consistent with the TechAccel business model, we are excited to take a key role in developing the science to expand the potential of Agrivida’s technology.”

Agrivida has a patented technology using protein expression in grain to simplify the process of enzyme production. The company is commercializing its patented GRAINZYME® feed additive enzymes for use with poultry, swine, dairy and beef cattle.

“TechAccel and Iowa Corn Opportunities are partners with the strategic commitment to advance the Agrivida vision,” said Dan Meagher, President and CEO of Agrivida. “Our technology promises improved production efficiency of major food segments, from plants to meat, milk and eggs.”

TechAccel is a venture and technology development company in agriculture and animal health sectors that invests in or acquires new technology and funds science advancement programs with research university partners to assist in commercialization.

The Iowa Corn Growers Association is a 7,500-member agricultural association with a long tradition of supporting Iowa corn farmers in lobbying and agricultural development. The association operates a wholly owned subsidiary, Iowa Corn Opportunities, as an equity fund to make strategic investments to benefit Iowa’s corn growers.

The two firms join a roster of current investors including the University of Texas Investment Management Company, ARCH Venture Partners, Cultivian Sandbox, Middleland Capital, Kleiner Perkins Caufield & Byers and Northgate Capital.

About Iowa Corn Opportunities

Iowa Corn Opportunities, LLC (ICO) is a limited liability company owned by the Iowa Corn Growers Association® (ICGA). ICO operates as an equity fund set up to assist new and growing companies that are developing businesses that are important to the corn industry. For more information visit, www.iowacornopportunities.com.

About TechAccel

TechAccel, LLC, was founded in 2014 as a first-of-its-kind venture and technology development company in the agriculture, animal health and food sectors. TechAccel sources, invests in and acquires early-stage innovations. Through collaborations with universities and research institutions, TechAccel conducts advancement and de-risking research and development to ready technologies for commercialization. For more information, visitwww.TechAccel.net or follow@Tech_Accel.

About Agrivida

Committed to using technology to improve the production of food for a growing global population, Agrivida scientists are experts in biochemistry, plant biology, molecular biology, agriculture, and nutrition. Founded in 2004 by scientists from the Massachusetts Institute of Technology who were focused on ways to improve the manufacture and use of enzymes, the company has been granted 33 patents, with more than 85 pending. The company’s innovative solutions have resulted in several research grants from both the U.S. Department of Agriculture and the U.S. Department of Energy. Additional information on the company can be found at www.agrivida.com.

Contacts

Treble
Ethan Parker, 512-960-8222
techaccel@treblepr.com

Agrivida Completes Initial Close Of Over $20 Million In Series E Funding

St Louis, Sept. 8, 2016 /PRNewswire/ — Agrivida Inc., an agritech company focused on animal nutrition, announces it has completed an initial close of $20.4 million Series E financing. The funds will be used to advance the commercialization of Agrivida’s patented GRAINZYME® feed additive enzymes for use with poultry and swine, and to support product development for dairy and beef cattle. The University of Texas Investment Management Company led the round and was joined by current investors ARCH Venture Partners, Cultivian Sandbox, Middleland Capital, Kleiner Perkins Caufield & Byers, and Northgate Capital.

“We’re excited to partner with the Agrivida team as the company prepares to commercialize its initial GRAINZYME products,” says Spencer Swayze of the University of Texas Investment Management Company that led the raise. “The company’s technology has the potential to improve the production efficiency for producers while reducing raw material and energy costs in the large and rapidly growing feed enzyme market.”

Company poised to launch breakthrough patented technologies

In addition to funding expansion of its capabilities and leadership team, the current financing will allow Agrivida to advance its regulatory and product development programs, and to execute a go-to-market commercialization plan for its patented GRAINZYME Phytase technology, which uses protein expression and storage in grain to simplify the process of enzyme production. The company expects to introduce its new products in early 2017, entering the feed enzyme market, which according to Research and Markets was valued at $1.1 billion in 2015, with an annual growth rate of 7 percent.

“This is another significant milestone for our company,” says Dan Meagher, CEO of Agrivida. “Exciting results from our recent animal trials are creating a convincing value proposition for the producers of food animals. We are looking forward to delivering on our promise of improving the production efficiency of meat, milk, and eggs to help address the growing global demand for food.”
About Agrivida

Committed to using technology to improve the production of food for a growing global population, Agrivida scientists are experts in biochemistry, plant biology, molecular biology, agriculture, and nutrition. Founded in 2004 by scientists from the Massachusetts Institute of Technology who were focused on ways to improve the manufacture and use of enzymes, the company has been granted 33 patents, with more than 85 pending. The company’s innovative solutions have resulted in several research grants from both the U.S. Department of Agriculture and the U.S. Department of Energy. Additional information on the company can be found at www.agrivida.com.

E-mail: pr@agrivida.com

Agrivida Closes $23 Million In Oversubscribed Series D Funding

Agrivida, Inc., an innovative technology company focused on animal nutrition, announced today that it has completed a $23 million Series D financing to advance the development and commercialization of its proprietary GraINzyme® feed additive enzymes and INergy™ silage technology platforms. Cultivian Sandbox Ventures led the round and was joined in the investment group by an affiliate of Maschhoff Family Foods, ARCH Venture Partners, Middleland Capital and existing investors Kleiner Perkins Caufield & Byers, DAG Ventures, Bright Capital Partners, Gentry Venture Partners, Northgate Capital, Prairie Gold and private investors. “We are excited to have this group of investors who are committed to our animal nutrition strategy and technology that will deliver unique enzyme solutions,” said Dan Meagher, CEO of Agrivida. “By using the corn plant as our factory combined with our proprietary technology, we aim to create a compelling value proposition to the producers of meat, milk and eggs to help address the growing global demand for food.” “Agrivida products offer dramatically improved cost performance while simplifying production, slashing capital expenditure requirements and reducing the carbon footprint of fermentation produced enzymes,” added Ron Meeusen, managing director of Cultivian Sandbox. “Agrivida holds the potential to disrupt this lucrative and growing feed enzyme market.” With this financing, Agrivida will further expand its capabilities, expertise and leadership team; advance its regulatory and product development; and focus on developing strategic commercial partnerships based on its proprietary GraINzyme® and INergyTM technology platforms. The funding will further support commercialization of its first products targeted for 2016.

About Agrivida

Agrivida, Inc., headquartered in Medford, Mass., is the global commercial leader in developing integrated enzyme solutions for the animal nutrition and health, energy and consumer products industries. The company has entered into research and development agreements with the U.S. Department of Energy (DOE), ARPA–E, the USDA, and other partner companies. With expertise in protein engineering, molecular biology, plant biotechnology, agronomy, and chemical engineering, Agrivida is developing innovative, sustainable crops and processes to meet demands for global food, consumer products and energy needs while protecting the environment. Additional information on the company can be found at www.agrivida.com.

E-mail: pr@agrivida.com

Agrivida Raises $12 Million In Series D Financing

Agrivida, Inc., an innovative technology company focused on animal nutrition, announced today that it has raised $12 million as part of a Series D financing to advance the development and commercialization of its proprietary GraINzyme® feed additive enzymes and INergyTM silage technology platforms. Cultivian Sandbox Ventures led the round. An affiliate of Maschhoff Family Foods, Middleland Capital and Sontag Family Trust joined as new Series D investors while Kleiner Perkins Caufield & Byers, DAG Ventures, Bright Capital Partners, Gentry Venture Partners, Northgate Capital and PrairieGold Venture Partners also participated.

“We view Agrivida as a very attractive investment and we like the company, strategy, direction and technology platforms,” said Ron Meeusen, Managing Partner of Cultivian Sandbox Ventures LLC. “We believe in the company’s strategy of delivering unique enzyme solutions that can help improve the economic efficiency of the global food system and industrial products used.”

“The commitment and confidence of our investors will help us advance our animal nutrition strategy,” said Dan Meagher, CEO of Agrivida. “By using the corn plant as our factory combined with our proprietary technology, we aim to create a compelling value proposition to the producers of meat, milk and eggs to help address the global demand for food. In a short period of time we have developed commercial partnership interest in our proprietary GraINzyme® and INergyTM technology platforms, confirming our vision and focus are on target.”

About Agrivida

Agrivida, Inc., headquartered in Medford, Mass., is the global commercial leader in developing integrated enzyme solutions for the animal nutrition and health, energy and consumer products industries. The company has entered into research and development agreements with the U.S. Department of Energy (DOE), ARPA–E, the USDA, and other partner companies. With expertise in protein engineering, molecular biology, plant biotechnology, agronomy, and chemical engineering, Agrivida is developing innovative, sustainable crops and processes to meet demands for global food, consumer products and energy needs while protecting the environment. Additional information on the company can be found at www.agrivida.com.

E-mail: pr@agrivida.com

Precision BioSciences and Agrivida Announce Collaborative Trait Development Agreement and Successful Genetic Modification Corn Traits for Improved Dairy and Beef Nutrition

Research Triangle Park, North Carolina and Medford, Massachusetts, March 10, 2014

Precision BioSciences and Agrivida revealed today that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision’s Directed Nuclease EditorTM (DNE) Technology. The collaboration recently delivered the first modified genes that are the subject of Agrivida commercialization efforts in the area of animal nutrition. Financial and other terms were not disclosed.

Agrivida is very pleased with the functional performance of Precision’s DNE technology. “The efficiency, ease-of-use, and the demonstrated utility of the technology confirm the important role that precise genome engineering will have in the future of agricultural biotechnology,” says Mike Lanahan, Agrivida VP of Business Development, Animal Nutrition. “Agrivida anticipates ongoing trait development using the technology in the collaboration with Precision.”

“Precision is excited by Agrivida’s results and we are thrilled to be working with an innovator in animal nutrition such as Agrivida,” says Matthew Kane, Precision CEO. “We are optimistic that the combination Agrivida’s unique understanding of plant metabolism and Precision’s DNE gene editing technology can be utilized to develop a strong pipeline of greatly needed agricultural product candidates.”

Dan Meagher, Agrivida CEO, says, “The opportunity for improving the nutritional characteristics of crops for the dairy and beef market segments is significant. Our results indicate that Precision technology has delivered a compositional modification that will benefit the industry by increasing the productivity of ruminant animals that consume plants expressing our trait.”

About Precision BioSciences

Precision BioSciences’ mission is to continually provide, improve, and enable the world’s most powerful genome engineering technology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant cells.

Precision BioSciences’ vision is to be the conduit through which the world’s greatest genome engineering challenges are solved. Precision has successfully utilized its DNE technology to create innovative products in partnerships with many of the world’s largest biopharmaceutical and agbiotech firms. Internally, Precision is developing DNE-based product leads for agricultural, biologics manufacturing and human therapeutic applications. For additional information, please visit www.precisionbiosciences.com.

About Agrivida

Agrivida’s mission is to deliver a New Generation of Enzyme Solutions where our technologies will play a role in helping feed the world more efficiently, improve resource utilization and foster environmental stewardship via the work of our dedicated employees.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstock and intermediate inputs. For additional information, please visit www.agrivida.com.

Contacts:

Precision BioSciences: Chelsea Lynam, phone: +1 919 314-5512
E-mail: Chelsea.Lynam@precisionbiosciences.com

Agrivida: Michael Raab, phone: +1 781 391-1262 (ext. 12)
E-mail: Michael.Raab@agrivida.com

Agrivida Announces Dan Meagher as Chief Executive Officer

Agrivida, Inc., a biotechnology company developing technologies for animal nutrition, cellulosic sugars from biomass, and regulated enzymes, announced today the appointment of Dan Meagher as Chief Executive Officer. Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities. Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills.

“I’m extremely excited to be joining Agrivida, whose technology represents a paradigm shift in delivering performance to the animal nutrition industry at the lowest cost possible,” stated Mr. Meagher.

Dan takes over at Agrivida as Mark Wong is named to Chairman of Agrivida’s Board of Directors.

“We are extremely fortunate to have Dan Meagher joining Agrivida to lead our team into this next phase of development,” said Mr. Wong. “Dan’s experience in the animal nutrition area will be critical to driving the commercialization of Agrivida’s technology in several areas.”

Mr. Wong assumes the chairman position following five years of service as Agrivida’s CEO. During his tenure, Mr. Wong led the company through several successful rounds of financing and established strategic relationships with corn seed and biofuels companies.

Agrivida’s new leadership team represents a broadening of the company’s expertise, reflecting its growing pipeline of biotechnology products for the animal nutrition, biofuels, and industrial enzyme markets.
About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. Agrivida is transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and intermediate inputs.

Agrivida Announces Appointments to its Board of Directors

Agrivida, Inc., a biotechnology company developing technology for animal nutrition, cellulosic sugars from biomass and regulated industrial enzymes, announced today the election of Edward L. McMillan and Robert S. Bucklin to the company’s Board of Directors.

Mr. McMillan was President and Chief Executive Officer of Purina Mills Inc., the United States’ largest manufacturer and distributor of animal nutrition products. A leading figure in the animal nutrition industry, Mr. McMillan served on the board of directors of the American Feed Industry Association and as Chairman of the Board in 1993-94. He serves on the board of directors of several food and agri-business related companies including Balchem Corporation (NASDAQ: BCPC); Durvet, Inc.; Newco Enterprises, Inc.; Certified Hereford Beef, LLC; and Glencoe Capital L.L.C. Consumer Products Executive Network. Mr. McMillan also serves on the board of trustees of the Universityof Illinois.

Mr. Bucklin was Vice Chairman of North America Wholesale banking for Rabobank International. He was responsible for the Wholesale Clients business (Corporate Banking, Mergers and Acquisitions, and Food & Agribusiness Research and Advisory) and Corporate Communications function in Rabobank’s U.S., Canada, and Mexico banking operations. He retired in July 2013. Mr. Bucklin was a member of the Management Teams of Rabobank’s North America Wholesale and global Wholesale Clients International divisions. He sat on the Management Development Committee, and for 17 years was a member of the Audit Committee, for Rabobank’s North America Wholesale operations.

“Agrivida is commercializing its technology programs with multiple industry partners. I am excited that we are now adding Ed and Bob, with their strategic expertise in animal nutrition, food and agri-business financing to the Board.” stated Mark Wong, CEO and Chairman, Agrivida.

About Agrivida, Inc.

Agrivida is developing and commercializing high-performance products that incorporate novel, regulated proteins precisely engineered for specific applications in a variety of markets, including animal feed and nutrition, bio-based fuels and chemicals, and industrial enzymes. We are transforming the economics of industrial and agricultural production through our pioneering use of regulated enzymes to develop higher-efficiency, lower-cost biomass feedstocks and
intermediate inputs.